-
- Comment in:
-
J Neurol Sci. 1998 Oct;160 Suppl 1:S25-9.
El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.
ALS Clinical Research Center, University of Wisconsin Hospital and Clinics, Clinical Science Center, Madison 53792-5132.
PMID: 7807156 [PubMed - indexed for MEDLINE]
-
Cited by 27 PubMed Central articles
-
Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.
Qureshi M, Brown RH Jr, Rogers JT, Cudkowicz ME.
Open Neurol J. 2008 Sep 12; 2:51-4. Epub 2008 Sep 12.
[Open Neurol J. 2008]
-
ReviewAmyotrophic lateral sclerosis.
Wijesekera LC, Leigh PN.
Orphanet J Rare Dis. 2009 Feb 3; 4:3. Epub 2009 Feb 3.
[Orphanet J Rare Dis. 2009]
-
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.
Sorenson EJ, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, et al.
Neurology. 2008 Nov 25; 71(22):1770-5.
[Neurology. 2008]
- » See all...